Inveready Technology Investment Group — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Ability Pharmaabilitypharma.com in 𝕏Mar 2024 · $8M

AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs.

BiotechDigital HealthHealthtechMedical DevicesGirona, ES

Carles Domenech(Founder)in

Co-investorsCapital Cell CTI Life Sciences Fund L.P.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.